ULIPs Should Not Be Advertised as ‘Investment Products’: IRDAI

[ad_1] Advertisements for all linked and annuity products with variable payouts must comply with the standards set by the ASCI, says IRDAI circular. All the advertisements of linked insurance products and annuity products with variable annuity payout option shall disclose the risk factors, says IRDAI master circular The Insurance Regulatory and Development Authority of India…

Read More

Post-Election Investment Guide: Strategies For Smart Investors

[ad_1] Navigating the post-election market requires a strategic approach rooted in valuation focus, sectoral diversification, etc. (Representative image) Given the current market dynamics, retail investors can employ several strategies to adapt and thrive. The recent re-election of Narendra Modi as India’s Prime Minister for a third term has sent ripples through the financial markets. With…

Read More

Rural India A ‘Bright Star’ for FMCG Sales; Will Continue to Outpace Urban Expansion in Q2 of 2024: Kantar

[ad_1] While urban is likely to remain under stress, the rural may consolidate its position in second quarter of the year. (Image of representation: AFP) Rural India will maintain “better growth levels” racing ahead of the urban markets for FMCG (fast-moving consumer goods) companies in the second quarter (April-June) of 2024, a Kantar report says…

Read More

TCS Shares Gain 2% As Company Signs Deal With Xerox To Transform IT Tech Using Cloud, GenAI

[ad_1] Last Updated: June 21, 2024, 13:37 IST Tata Consultancy Services (TCS) has expanded its partnership with Xerox to fast-track the evolution of the company to a simplified, services-led, software-enabled organization, the company informed the exchange in a filing on Friday. It has expanded its strategic partnership with Xerox with an “end-to-end transformation program designed…

Read More

SRPT, HTZ, ASAN and more

[ad_1] Check out the companies making headlines in midday trading. Sarepta Therapeutics — Shares of the biopharma company surged 33% after the U.S. Food and Drug Administration approved the expanded use of the company’s gene therapy, Elevidys, for Duchenne muscular dystrophy. The FDA granted traditional approval of the therapy for patients 4 years and older…

Read More

OpenAI Founder Sutskever Sets Up New AI Company Devoted to ‘Safe Superintelligence’

[ad_1] At OpenAI, Ilya Sutskever jointly led a team focused on safely developing better-than-human AI known as artificial general intelligence, or AGI. (Photo Credit: X) Ilya Sutskever, a respected AI researcher who left the ChatGPT maker last month, says in a social media post on Wednesday that he’s created Safe Superintelligence Inc. with two co-founders…

Read More